Annual Total Long Term Liabilities
$93.33 M
-$100.71 M-51.90%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual total long term liabilities is $93.33 million, with the most recent change of -$100.71 million (-51.90%) on December 31, 2023.
- During the last 3 years, CTMX annual total long term liabilities has fallen by -$205.00 million (-68.72%).
- CTMX annual total long term liabilities is now -68.72% below its all-time high of $298.33 million, reached on December 31, 2020.
Performance
CTMX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$43.20 M
-$4.38 M-9.21%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly total long term liabilities is $43.20 million, with the most recent change of -$4.38 million (-9.21%) on September 30, 2024.
- Over the past year, CTMX quarterly long term liabilities has dropped by -$82.41 million (-65.61%).
- CTMX quarterly long term liabilities is now -85.52% below its all-time high of $298.33 million, reached on December 31, 2020.
Performance
CTMX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CTMX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.9% | -65.6% |
| 3 y3 years | -68.7% | -65.6% |
| 5 y5 years | -59.1% | -65.6% |
CTMX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.4% | at low | -83.5% | at low |
| 5 y | 5-year | -68.7% | at low | -85.5% | at low |
| alltime | all time | -68.7% | +71.9% | -85.5% | at low |
CytomX Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $43.20 M(-9.2%) |
| Jun 2024 | - | $47.59 M(-33.8%) |
| Mar 2024 | - | $71.83 M(-23.0%) |
| Dec 2023 | $93.33 M(-51.9%) | $93.33 M(-25.7%) |
| Sep 2023 | - | $125.61 M(-17.8%) |
| Jun 2023 | - | $152.84 M(-10.1%) |
| Mar 2023 | - | $170.00 M(-12.4%) |
| Dec 2022 | $194.03 M(-25.9%) | $194.03 M(+93.7%) |
| Sep 2022 | - | $100.18 M(-10.5%) |
| Jun 2022 | - | $111.94 M(-11.1%) |
| Mar 2022 | - | $125.86 M(-52.0%) |
| Dec 2021 | $262.00 M(-12.2%) | $262.00 M(+64.0%) |
| Sep 2021 | - | $159.79 M(-10.3%) |
| Jun 2021 | - | $178.11 M(-6.3%) |
| Mar 2021 | - | $190.09 M(-36.3%) |
| Dec 2020 | $298.33 M(+45.8%) | $298.33 M(+32.5%) |
| Sep 2020 | - | $225.09 M(-8.1%) |
| Jun 2020 | - | $244.87 M(-6.1%) |
| Mar 2020 | - | $260.89 M(+27.5%) |
| Dec 2019 | $204.58 M | $204.58 M(-4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $214.31 M(-4.8%) |
| Jun 2019 | - | $225.11 M(-0.3%) |
| Mar 2019 | - | $225.72 M(-1.1%) |
| Dec 2018 | $228.32 M(-14.4%) | $228.32 M(-4.4%) |
| Sep 2018 | - | $238.79 M(-5.5%) |
| Jun 2018 | - | $252.60 M(-1.8%) |
| Mar 2018 | - | $257.11 M(-3.6%) |
| Dec 2017 | $266.60 M(+214.1%) | $266.60 M(-1.4%) |
| Sep 2017 | - | $270.32 M(+13.1%) |
| Jun 2017 | - | $238.98 M(+256.9%) |
| Mar 2017 | - | $66.97 M(-21.1%) |
| Dec 2016 | $84.88 M(+53.2%) | $84.88 M(+6.4%) |
| Sep 2016 | - | $79.78 M(-4.4%) |
| Jun 2016 | - | $83.45 M(+34.1%) |
| Mar 2016 | - | $62.23 M(+12.3%) |
| Dec 2015 | $55.41 M(-60.5%) | $55.41 M(-74.4%) |
| Sep 2015 | - | $216.85 M(+264.2%) |
| Jun 2015 | - | $59.55 M(-57.6%) |
| Dec 2014 | $140.44 M(+158.7%) | $140.44 M |
| Dec 2013 | $54.29 M | - |
FAQ
- What is CytomX Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for CytomX Therapeutics?
- What is CytomX Therapeutics annual total long term liabilities year-on-year change?
- What is CytomX Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly long term liabilities year-on-year change?
What is CytomX Therapeutics annual total long term liabilities?
The current annual total long term liabilities of CTMX is $93.33 M
What is the all time high annual total long term liabilities for CytomX Therapeutics?
CytomX Therapeutics all-time high annual total long term liabilities is $298.33 M
What is CytomX Therapeutics annual total long term liabilities year-on-year change?
Over the past year, CTMX annual total long term liabilities has changed by -$100.71 M (-51.90%)
What is CytomX Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of CTMX is $43.20 M
What is the all time high quarterly long term liabilities for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly total long term liabilities is $298.33 M
What is CytomX Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, CTMX quarterly total long term liabilities has changed by -$82.41 M (-65.61%)